66 related articles for article (PubMed ID: 21835235)
1. Rubratoxin B induces signs of fatty acid oxidation disorders (FAODs) in mice.
Iwashita K; Nagashima H
Toxicol Lett; 2011 Oct; 206(2):238-43. PubMed ID: 21835235
[TBL] [Abstract][Full Text] [Related]
2. The phosphorylation state of the cAMP response element binding protein is decreased in diabetic rat liver.
Davies GF; Crosson SM; Khandelwal RL; Roesler WJ
Arch Biochem Biophys; 1995 Nov; 323(2):477-83. PubMed ID: 7487114
[TBL] [Abstract][Full Text] [Related]
3. Effect of reduced maternal inspired oxygen on hepatic glucose metabolism in the rat fetus.
Parimi PS; Croniger CM; Leahy P; Hanson RW; Kalhan SC
Pediatr Res; 2003 Feb; 53(2):325-32. PubMed ID: 12538794
[TBL] [Abstract][Full Text] [Related]
4. Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth.
Croniger C; Trus M; Lysek-Stupp K; Cohen H; Liu Y; Darlington GJ; Poli V; Hanson RW; Reshef L
J Biol Chem; 1997 Oct; 272(42):26306-12. PubMed ID: 9334201
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.
Kaidanovich-Beilin O; Eldar-Finkelman H
J Pharmacol Exp Ther; 2006 Jan; 316(1):17-24. PubMed ID: 16169938
[TBL] [Abstract][Full Text] [Related]
6. Rubratoxin B induces interleukin-6 secretion in mouse white adipose tissues and 3T3-L1 adipocytes.
Iwashita K; Nagashima H
Toxicol Lett; 2008 Nov; 182(1-3):79-83. PubMed ID: 18804154
[TBL] [Abstract][Full Text] [Related]
7. Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes.
Murakami R; Murakami H; Kataoka H; Cheng XW; Takahashi R; Numaguchi Y; Murohara T; Okumura K
Life Sci; 2010 Oct; 87(15-16):495-500. PubMed ID: 20849861
[TBL] [Abstract][Full Text] [Related]
8. Evidence for selective induction of phosphoenolpyruvate carboxykinase gene expression by unsaturated and nonmetabolized fatty acids in adipocytes.
Duplus E; Glorian M; Tordjman J; Berge R; Forest C
J Cell Biochem; 2002; 85(3):651-61. PubMed ID: 11968005
[TBL] [Abstract][Full Text] [Related]
9. Regulation of phosphoenolpyruvate carboxykinase mRNA in mouse liver, kidney, and fat tissues by fasting, diabetes, and insulin.
Nandan SD; Beale EG
Lab Anim Sci; 1992 Oct; 42(5):473-7. PubMed ID: 1460846
[TBL] [Abstract][Full Text] [Related]
10. Activity and mRNA levels of enzymes involved in hepatic fatty acid oxidation in mice fed citrus flavonoids.
Huong DT; Takahashi Y; Ide T
Nutrition; 2006 May; 22(5):546-52. PubMed ID: 16483743
[TBL] [Abstract][Full Text] [Related]
11. Regulation of messenger ribonucleic acid expression for gluconeogenic enzymes during glucagon infusions into lactating cows.
She P; Lindberg GL; Hippen AR; Beitz DC; Young JW
J Dairy Sci; 1999 Jun; 82(6):1153-63. PubMed ID: 10386301
[TBL] [Abstract][Full Text] [Related]
12. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats.
Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT
Life Sci; 2006 Jun; 79(3):240-6. PubMed ID: 16458327
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated increase in HNF-3beta or HNF-3alpha shows differences in levels of liver glycogen and gene expression.
Tan Y; Hughes D; Wang X; Costa RH
Hepatology; 2002 Jan; 35(1):30-9. PubMed ID: 11786957
[TBL] [Abstract][Full Text] [Related]
14. Role of Krüppel-like factor 15 in PEPCK gene expression in the liver.
Teshigawara K; Ogawa W; Mori T; Matsuki Y; Watanabe E; Hiramatsu R; Inoue H; Miyake K; Sakaue H; Kasuga M
Biochem Biophys Res Commun; 2005 Feb; 327(3):920-6. PubMed ID: 15649433
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin induced hyperlactatemia and hypoglycemia is linked to decreased mitochondrial phosphoenolpyruvate carboxykinase.
Caton PW; Nayuni NK; Murch O; Corder R
Life Sci; 2009 May; 84(21-22):738-44. PubMed ID: 19268478
[TBL] [Abstract][Full Text] [Related]
16. Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein alpha.
Yang J; Croniger CM; Lekstrom-Himes J; Zhang P; Fenyus M; Tenen DG; Darlington GJ; Hanson RW
J Biol Chem; 2005 Nov; 280(46):38689-99. PubMed ID: 16166091
[TBL] [Abstract][Full Text] [Related]
17. Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta have an attenuated response to cAMP and impaired carbohydrate metabolism.
Croniger CM; Millward C; Yang J; Kawai Y; Arinze IJ; Liu S; Harada-Shiba M; Chakravarty K; Friedman JE; Poli V; Hanson RW
J Biol Chem; 2001 Jan; 276(1):629-38. PubMed ID: 11024029
[TBL] [Abstract][Full Text] [Related]
18. Acute and selective inhibition of adipocyte glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase by interferon gamma.
Khazen W; Distel E; Collinet M; Chaves VE; M'Bika JP; Chany C; Achour A; Benelli C; Forest C
Endocrinology; 2007 Aug; 148(8):4007-14. PubMed ID: 17495004
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone corrects proliferation and transcription of phosphoenolpyruvate carboxykinase in livers of old mice via elimination of CCAAT/enhancer-binding protein alpha-Brm complex.
Wang GL; Shi X; Salisbury E; Sun Y; Albrecht JH; Smith RG; Timchenko NA
J Biol Chem; 2007 Jan; 282(2):1468-78. PubMed ID: 17107955
[TBL] [Abstract][Full Text] [Related]
20. Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism.
She P; Shiota M; Shelton KD; Chalkley R; Postic C; Magnuson MA
Mol Cell Biol; 2000 Sep; 20(17):6508-17. PubMed ID: 10938127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
